The opening session was attended by Vítor Martins, director of the Cardiology Service at ULS Lezíria; Pedro Marques, chairman of the Board of Directors; Teresa Rodrigues, clinical director for Hospital Healthcare; and Ana Calado, clinical director for Primary Healthcare of the institution.
The scientific program highlighted cardiomyopathies, including cardiac ATTR amyloidosis and hypertrophic cardiomyopathy, as well as the most recent clinical recommendations on dyslipidemias, heart failure, and cardiovascular disease in pregnancy.
Therapeutic innovation was the focus of a session on mavacamten in the treatment of obstructive hypertrophic cardiomyopathy. During the afternoon, sudden cardiac death, new cardiac pacing solutions, and artificial intelligence as a tool to support medical practice were discussed.
The program also included sessions on adult vaccination and vascular surgery, with a focus on carotid stenting at ULS Lezíria and complications of vascular access after cardiological procedures.
